NAL develops BiPAP Non-Invasive Ventilator SwasthVayu in 36 days for coronavirus
CSIR-National Aerospace Laboratories (NAL) Bangalore has
developed SwasthVayu, a Non-Invasive Bilevel Positive Airway Pressure (BiPAP)
Ventilator in a record time of 36 days to treat COVID-19 patients.
SwasthVayu: A fact file
ventilator is a microcontroller-based precise closed-loop adaptive control
system with a built-in biocompatible 3D printed manifold & coupler with
Highly Efficient Particulate Air Filter (HEPA Filter).
he system has been
developed with unique features help to alleviate the fear of the virus spread.
It has features like Spontaneous, CPAP, Timed, AUTO BIPAP modes with provision
to connect Oxygen concentrator or Enrichment unit externally.
The system has been
certified for safety and performance by NABL accredited agencies.
The system has
undergone stringent biomedical tests and beta clinical trials at NAL Health
SwasthVayu machine is
simple to use without any specialized nursing, cost-effective, compact and
configured with a majority of indigenous components.
Ventilator has been developed with an externally connected Oxygen concentrator
which will be ideal to treat moderate or mid-stage severe COVID-19 patients who
do not require intubation and invasive ventilation.